tiprankstipranks
TG Therapeutics (CH:NKB2)
:NKB2
Switzerland Market

TG Therapeutics (NKB2) Earnings Dates, Call Summary & Reports

0 Followers

Earnings Data

Report Date
Nov 09, 2026
TBA (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
0.29
Last Year’s EPS
1.97
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings

TG Therapeutics (CH:NKB2) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:NKB2 Q2 2026 Earnings Report

CH:NKB2 Upcoming Earnings
TG Therapeutics's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

CH:NKB2 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 09, 2026
2026 (Q3)
0.29 / -
1.967
2026 (Q2)
0.25 / 0.04
0.138-70.59% (-0.10)
2026 (Q1)
0.22 / 0.10
0.024300.00% (+0.07)
2025 (Q4)
0.28 / 0.11
0.121-6.67% (>-0.01)
2025 (Q3)
0.18 / 1.97
0.01612050.00% (+1.95)
2025 (Q2)
0.17 / 0.14
0.032325.00% (+0.11)
2025 (Q1)
0.14 / 0.02
-0.057142.86% (+0.08)
2024 (Q4)
0.13 / 0.12
-0.073266.67% (+0.19)
2024 (Q3)
0.02 / 0.02
0.591-97.26% (-0.57)
2024 (Q2)
-0.04 / 0.03
-0.275111.76% (+0.31)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FAQ

When does TG Therapeutics (CH:NKB2) report earnings?
TG Therapeutics (CH:NKB2) is schdueled to report earning on Nov 09, 2026, TBA (Confirmed).
    What is TG Therapeutics (CH:NKB2) earnings time?
    TG Therapeutics (CH:NKB2) earnings time is at Nov 09, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of TG Therapeutics stock?
          The P/E ratio of TG Therapeutics is N/A.
            What is CH:NKB2 EPS forecast?
            CH:NKB2 EPS forecast for the fiscal quarter 2026 (Q3) is 0.29.